{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T10:56:21Z","timestamp":1773658581328,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":115,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd006391","type":"reference-entry","created":{"date-parts":[[2007,1,25]],"date-time":"2007-01-25T13:35:23Z","timestamp":1169732123000},"source":"Crossref","is-referenced-by-count":47,"title":["Benzodiazepines for schizophrenia"],"prefix":"10.1002","author":[{"given":"Anja","family":"Volz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesal","family":"Khorsand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donna","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,1,24]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD006391-BIB1|cit1","first-page":"44","article-title":"The effects of chlordiazepoxide (librium) in anxiety states: A multi-blind study","volume":"7","author":"Azima","year":"1962","journal-title":"Canadian Psychiatric Journal"},{"key":"10.1002\/14651858.CD006391-BIB2|cit2","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1176\/ajp.149.4.506","article-title":"Alprazolam as a neuroleptic adjunct in the emergency treatment of schizophrenia [published erratum appears in American Journal of Psychiatry 1992 ;149(8):1129] [see comments]","volume":"149","author":"Barbee","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB3|cit3","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0735-6757(97)90119-4","article-title":"Haloperidol, lorazepam, or both for psychotic agitation? A multicenter, prospective, double-blind, emergency department study","volume":"15","author":"Battaglia","year":"1997","journal-title":"American Journal of Emergency Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB4|cit4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1176\/ajp.156.2.299","article-title":"Diazepam Treatment of Early Signs of Exacerbation in Schizophrenia","volume":"156","author":"Carpenter","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB5|cit5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1192\/bjp.138.6.490","article-title":"Schizophrenics fully remitted on neuroleptics for 3-5 years-To stop or continue drugs?","volume":"138","author":"Cheung","year":"1981","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB6|cit6","first-page":"114","article-title":"A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms [see comments]","volume":"38 Suppl 4","author":"Chouinard","year":"1993","journal-title":"Canadian Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB7|cit7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0006-3223(96)00367-8","article-title":"Treatment of long-term tardive dyskinesia with Vitamin E","volume":"41","author":"Dorevitch","year":"1997","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB8|cit8","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/ajp.156.1.142","article-title":"Intramuscular flunitrazepam versus intramuscular haloperidol in the emergency treatment of aggressive psychotic behavior","volume":"156","author":"Dorevith","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB9|cit9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00004850-199705000-00009","article-title":"Efficacy of lorazepam and haloperidol for rapid tranquilization in a psychiatric emergency room setting","volume":"12","author":"Foster","year":"1997","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD006391-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1176\/ajp.146.12.1598","article-title":"Efficacy of combinations of intramuscular antipsychotics and sedative-hypnotics for control of psychotic agitation","volume":"146","author":"Garza-Trevino","year":"1989","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB11|cit11","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00404713","article-title":"A Double-blind outpatient study of diazepam (Valium) and placebo","volume":"9","author":"Gundlach","year":"1966","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD006391-BIB13|cit12","first-page":"205","article-title":"Lorazepam and haloperidol in the treatment of schizophrenic patients","volume":"37","author":"Guz","year":"1988","journal-title":"Jornal Brasileiro de Psiquiatria"},{"key":"10.1002\/14651858.CD006391-BIB12|cit13","first-page":"767","article-title":"The therapeutic effects of lorazepam in psychotic patients treated with haloperidol - A double blind study","volume":"14","author":"Guz","year":"1972","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006391-BIB14|cit14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/009127006200200305","article-title":"A reference study of ataraxics. A two-week double blind outpatient evaluation","volume":"179","author":"Hankoff","year":"1962","journal-title":"The Journal of New Drugs"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB15|cit15","first-page":"169","article-title":"Combined drug treatment of newly hospitalized, acutely ill psychiatric patients","volume":"30","author":"Hanlon","year":"1969","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB16|cit16","first-page":"1","article-title":"Comparative effects of fluphenazine, fluphenazine-chlordiazepoxide and fluphenazine-imipramine","volume":"17","author":"Hanlon","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB17|cit17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000468187","article-title":"Effects od control techniques on therapeutic outcome in a controlled trial","volume":"10","author":"Hanlon","year":"1975","journal-title":"International Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB18|cit18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0033-3182(70)71576-4","article-title":"Weight changes with schizophrenic psychosis and psychotropic drug therapy","volume":"11","author":"Holden","year":"1970","journal-title":"Psychosomatics"},{"key":"10.1002\/14651858.CD006391-BIB20|cit19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/070674376901400311","article-title":"Laboratory changes with chlordiazepoxide and thioridazine, alone and combined","volume":"14","author":"Holden","year":"1969","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD006391-BIB19|cit20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0010-440X(68)80059-8","article-title":"Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia","volume":"9","author":"Holden","year":"1968","journal-title":"Comprehensive Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB21|cit21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/009127006600600203","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment: side effects and clinical laboratory findings","volume":"6","author":"Kurland","year":"1966","journal-title":"Journal of New Drugs"},{"key":"10.1002\/14651858.CD006391-BIB22|cit22","first-page":"117","article-title":"Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients","volume":"8 suppl","author":"Michaux","year":"1966","journal-title":"Current Therapeutic Research Clininical and Experimental"},{"key":"10.1002\/14651858.CD006391-BIB23|cit23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00004714-198912000-00003","article-title":"Successful clonazepam treatment of neurleptic-induced akathisia in older adolescents and young adults: a double-blind, placebo-controlled study","volume":"9","author":"Kutcher","year":"1989","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006391-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1176\/ajp.136.8.1061","article-title":"Acute high-dose parenteral haloperidol treatment of psychosis","volume":"136","author":"Lerner","year":"1979","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD006391-BIB25|cit25","first-page":"505","article-title":"Antipsychotic effect of diazepam when given in addition to neuroleptics in chronic psychotic patients - A double-blind clinical trial","volume":"26","author":"Lingjaerde","year":"1979","journal-title":"Current Therapeutic Research"},{"key":"10.1002\/14651858.CD006391-BIB26|cit26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1600-0447.1982.tb00855.x","article-title":"Effect of the benzodiazepine derivative estazolam in patients with auditory hallucinations. A multicentre double-blind, cross-over study","volume":"65","author":"Lingjaerde","year":"1982","journal-title":"Acta Psychiatrica Scandinavia"},{"key":"10.1002\/14651858.CD006391-BIB27|cit27","first-page":"7533","article-title":"Anxiolytische Zusatzbehandlung bei der affekbetonten Schizophrenien. Ein Doppelblindversuch","volume":"44","author":"Marneros","year":"1979","journal-title":"Therapiewoche 29"},{"key":"10.1002\/14651858.CD006391-BIB28|cit28","first-page":"133","article-title":"A double-blind comparison of diazepam, chlordiazepoxide and chlorpromazine in psychotic patients","volume":"3","author":"Merlis","year":"1962","journal-title":"Journal of Neuropsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB29|cit29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1055\/s-2007-1014491","article-title":"Double blind, controlled study of the efficacy and safety of alpidem in the treatment of anxiety in schizophrenic in-patients","volume":"23","author":"Minervini","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB30|cit30","first-page":"551","article-title":"A double-blind comparison of alprazolam and placebo in the treatment of anxious schizophrenic outpatients","volume":"40","author":"Morphy","year":"1986","journal-title":"Current Therapeutic Research"},{"issue":"4-6","key":"10.1002\/14651858.CD006391-BIB31|cit31","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0278-5846(82)80141-3","article-title":"Diazepam in high doses is effective in schizophrenia","volume":"6","author":"Nestoros","year":"1982","journal-title":"Progress in Neuro- Psychopharmacolgy and Biological Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB32|cit32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00432759","article-title":"Prophylactic effect of neuroleptics in symptom-free schizophrenics","volume":"77","author":"Nishikawa","year":"1982","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB33|cit33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00002826-199406000-00003","article-title":"A double-blind comparison of clonazepam and placebo in the treatment of neuroleptic-induced akathisia","volume":"17","author":"Puljalte","year":"1994","journal-title":"Clinical Neuropharmacology"},{"key":"10.1002\/14651858.CD006391-BIB34|cit34","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-2007-1014421","article-title":"Haloperidol and lorazepam combined: clinical effects and drug plasma levels in the treatment of acute schizophrenic psychosis","volume":"25","author":"Stevens","year":"1992","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB35|cit35","first-page":"1","article-title":"Rapid tranquillisation for agitated patients in emergency psychiatric rooms: a randomised trial of midazolam versus haloperidol plus promethiazine","volume":"327","year":"2003","journal-title":"British Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB36|cit36","first-page":"217","article-title":"An efficacy study of risperidone combined with clonazepam injection in the treatment of paranoid schizophrenia","volume":"13","author":"Wang","year":"2003","journal-title":"Journal of Clinical Psychologic Medicine"},{"key":"10.1002\/14651858.CD006391-BIB37|cit37","first-page":"126","article-title":"The use of midazolam in acutely agitated psychiatric patients","volume":"26","author":"Wyant","year":"1990","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006391-BIB38|cit38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/00004714-198506000-00009","article-title":"Efficacy of propranolol in neuroleptic-induced akathesia","volume":"5","author":"Adler","year":"1985","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006391-BIB39|cit39","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/j.1600-0447.1987.tb02942.x","article-title":"Clonazepam\/haloperidol combination therapy in schizophrenia: A double blind study","volume":"76","author":"Altamura","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006391-BIB40|cit40","first-page":"133","article-title":"Doxepin in geriatric patients","volume":"25","author":"Ananth","year":"1979","journal-title":"Current Therapeutic Research"},{"issue":"1","key":"10.1002\/14651858.CD006391-BIB41|cit41","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/j.1875-9114.1998.tb03827.x","article-title":"A double-blind study of lorazepam versus the combination of haloperidol and lorazepam in managing agitation","volume":"18","author":"Bienek","year":"1998","journal-title":"Pharmacotherapy"},{"key":"10.1002\/14651858.CD006391-BIB42|cit42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1176\/ajp.138.2.189","article-title":"Clonazepam and phenobarbital in tardive dyskinesia","volume":"138","author":"Bobruff","year":"1981","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB43|cit43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000118386","article-title":"Adjunctive benzodiazepines in acute schizophrenia","volume":"18","author":"Cohen","year":"1987","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1002\/14651858.CD006391-BIB44|cit44","first-page":"1623","article-title":"Clinical trials of sulpiride (1403 R.D.--Dogmatil): Its advantages prescribed alone or in combination","volume":"6","author":"Crosse","year":"1974","journal-title":"Psychologie M\u00e9dicale"},{"key":"10.1002\/14651858.CD006391-BIB45|cit45","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1001\/archpsyc.1988.01800310063008","article-title":"Double-blind comparison fo alprazolam, diazepam, and placebo for the treatment of negative symptoms","volume":"45","author":"Csernansky","year":"1988","journal-title":"Archive General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB46|cit46","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00004714-198804000-00028","article-title":"The effect of benzodiazepines on tardive dyskinesia symptoms","volume":"8","author":"Csernansky","year":"1988","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD006391-BIB47|cit47","first-page":"5","article-title":"Rapid tranquilization: antipsychotics or benzodiazepines","volume":"49","author":"Dubin","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1176\/ajp.144.9.1224","article-title":"Treatment of catatonia with low-dose lorazepam","volume":"144","author":"Greenfeld","year":"1987","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB49|cit49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000117886","article-title":"Analgesic and euphoric effects of high dose diazepam in schizophrenia","volume":"8","author":"Haas","year":"1982","journal-title":"Neuropsychobiology"},{"key":"10.1002\/14651858.CD006391-BIB50|cit50","first-page":"349","article-title":"A new tranquilizer: lorazepam (158 cases)","volume":"49","author":"Hanus","year":"1973","journal-title":"Semaine des Hopitaux (Therapeutique)"},{"key":"10.1002\/14651858.CD006391-BIB51|cit51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1978.tb06915.x","article-title":"A controlled long-term study of flunitrazepam, nitrazepam and placebo, with special regard to withdrawal effects","volume":"58","author":"Hartelius","year":"1978","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD006391-BIB52|cit52","first-page":"675","article-title":"A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male Schizophrenic patients","volume":"28","author":"Hekimian","year":"1967","journal-title":"Diseases of Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB53|cit53","first-page":"13","article-title":"Clinical trial with a new substance (PLP 100-127) in order to asses therapeutic efficacy and dependence creating properties","volume":"7","author":"Hesso","year":"1975","journal-title":"Behavioral Neuropsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB54|cit54","first-page":"733","article-title":"Usefulness of antiparkinsonian drugs during neuroleptic treatment and the effect of clonazepam on akathisia and parkinsonism occurred after antiparkinsonian drug withdrawal: a double-blind study","volume":"46","author":"Horiguchi","year":"1992","journal-title":"Japanese Journal of Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD006391-BIB55|cit55","first-page":"15","article-title":"SCH-12,041, a new anti-anxiety agent (quantitative pharmaco-electroencephalography and clinical trials)","volume":"4","author":"Itil","year":"1972","journal-title":"Behavioral Neuropsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB56|cit56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00194407","article-title":"Beneficial effect of high-dose clotiazepam on intractable auditory hallucinations in chronic schizophrenic patients. An open trial","volume":"46","author":"Jibiki","year":"1994","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB57|cit57","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/ajp.139.4.489","article-title":"Diazepam in schizophrenia: a preliminary double-blind trial","volume":"139","author":"Jimerson","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB58|cit58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1055\/s-2007-1017412","article-title":"Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 in schizophrenic patients. A double blind trial","volume":"17","author":"Jungkunz","year":"1984","journal-title":"Pharmacopsychiatry"},{"key":"10.1002\/14651858.CD006391-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1176\/ajp.139.12.1627","article-title":"Clonazepam treatment of chronic schizophrenia: negative results in a double-blind, placebo-controlled trial","volume":"139","author":"Karson","year":"1982","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/archpsyc.1975.01760280044004","article-title":"Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study","volume":"32","author":"Kellner","year":"1975","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB61|cit61","first-page":"1251","article-title":"Wirkungsvergleich zweier Benzodiazepine bei psychovegetativen Allgemeinst\u00f6rungen.","volume":"33","author":"Maar","year":"1983","journal-title":"Therapiewoche"},{"key":"10.1002\/14651858.CD006391-BIB62|cit62","first-page":"390","article-title":"Chlordiazepoxide in the treatment of patients with \"activated EEG's\"","volume":"28","author":"Monroe","year":"1967","journal-title":"Diseases of Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB63|cit63","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00439272","article-title":"High doses of diazepam improve neuroleptic-resistant chronic schizophrenic patients","volume":"81","author":"Nestros","year":"1983","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB64|cit64","first-page":"263","article-title":"Benzodiazepine augmentation of neuroleptic treatment in patients with schizophrenia","volume":"25","author":"Pato","year":"1989","journal-title":"Psychopharmacology Bulletin"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB65|cit65","first-page":"82","article-title":"Survey of the adjuvant use of benzodiazepines for treating outpatients with schizophrenia","volume":"18","author":"Pecknold","year":"1993","journal-title":"The Journal of Psychiatric Neurosciences"},{"key":"10.1002\/14651858.CD006391-BIB66|cit66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/070674379303800404","article-title":"Placebo response in refractory tardive akathisia","volume":"38","author":"Remington","year":"1993","journal-title":"Canadian Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB67|cit67","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0736-4679(98)00045-6","article-title":"Chemical restraint for the agitated patient in the emergency department: lorazepam versus droperidol","volume":"16","author":"Richards","year":"1998","journal-title":"The Journal of Emergency Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB68|cit68","first-page":"557","article-title":"Benzodiazepind in chronic schizophrenia","volume":"14","author":"Ruskin","year":"1979","journal-title":"Biological Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD006391-BIB69|cit69","first-page":"16","article-title":"Lorazepam treatment of psyhcogenic catatonia: an update","volume":"49","author":"Salam","year":"1988","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB70|cit70","first-page":"349","article-title":"Effect of minor and major tranquilizers on somatosensory evoked potentials","volume":"24","author":"Saletu","year":"1971","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD006391-BIB71|cit71","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/106002808602000418","article-title":"Behavioral side effects of triazolam in psychiatric inpatients: report of five cases","volume":"20","author":"Soldatos","year":"1986","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"10.1002\/14651858.CD006391-BIB72|cit72","first-page":"50","article-title":"Doxepin as adjuvant medication in the treatment of chronic schizophrenic patients: a comparative study","volume":"13","author":"Sterlin","year":"1971","journal-title":"Current Therapy Research Clinical and Experimental"},{"issue":"6","key":"10.1002\/14651858.CD006391-BIB73|cit73","first-page":"411","article-title":"A comparative study with Benzodiazepines in chronic psychotic patients","volume":"27","author":"Stonehill","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB74|cit74","series-title":"A prospective randomised double blind controlled study of the efficacy of Lorazepam versus Clothiapine in the control of acutely behaviourally disturbed patients","author":"Subramaney"},{"key":"10.1002\/14651858.CD006391-BIB75|cit75","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.185.1.63","article-title":"Rapid tranquilisation of violent or agitated patients in a psychiatric emergency setting: a pragmatic randomised trial of intramuscular lorazepam versus haloperidol olus promethiazine.","volume":"185","author":"Alexander","year":"2004","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB76|cit76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/106002808301700705","article-title":"Diazepam in tardive dyskinesia","volume":"17","author":"Weber","year":"1983","journal-title":"Drug Intelligence and Clinical Pharmacy"},{"key":"10.1002\/14651858.CD006391-BIB77|cit77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ajp.143.1.85","article-title":"Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia","volume":"143","author":"Wolkowitz","year":"1986","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB78|cit78","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1001\/archpsyc.1988.01800310072009","article-title":"Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients - Preliminary results","volume":"45","author":"Wolkowitz","year":"1988","journal-title":"Archives of General Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB79|cit79","first-page":"98","article-title":"A randomly controlled comparison of risperidone added with intramuscular clonazepam in the treatment of excitement of schizophrenia","volume":"15","author":"Yang","year":"2003","journal-title":"Shanghai Archives of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB80|cit80","first-page":"164","article-title":"Comparison of diazepam, chlorprothixine and chlorpromazine in chronic schizophrenic patients","volume":"25","author":"Maculans","year":"1964","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD006391-BIB81|cit81","first-page":"177","article-title":"Parenteral lorazepam versus parenteral haloperidol for the control of psychotic disruptive behavior","volume":"52","author":"Salzman","year":"1991","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB82|cit82","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s002130050904","article-title":"Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study","volume":"142","author":"Ungvari","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD006391-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006391-BIB84|cit84","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1192\/S0007125000291496","article-title":"Scale for the assessment of negative symptoms","volume":"155","author":"Andreasen","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB85|cit85","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004028.pub2","article-title":"Valproate for schizophrenia","author":"Basan","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006391-BIB86|cit86","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials: the CONSORT statement","volume":"276","author":"Beg","year":"1996","journal-title":"Journal of American Medicale Assosiation"},{"key":"10.1002\/14651858.CD006391-BIB87|cit87","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters.","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB88|cit88","article-title":"Beta-blocker supplementation of standard drug treatment for schizophrenia.","author":"Cheine","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006391-BIB89|cit89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/schbul\/17.2.217","article-title":"When symptoms persist: choosing among alternative somatic treatments for schizophrenia","volume":"17","author":"Christison","year":"1991","journal-title":"Schizophrenia Bulletin"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB90|cit90","article-title":"Antipsychotic combinations for schizophrenia","author":"Correll","year":"2004","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB91|cit91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/01688638908400888","article-title":"Development of a scale for assessment of agitation following traumatic brain injury.","volume":"11","author":"Corrigan","year":"1989","journal-title":"Journal of Clinical and Experimental Neuropsychology"},{"key":"10.1002\/14651858.CD006391-BIB92|cit92","series-title":"Abstracts of 8th International Cochrane Colloquium","article-title":"Issues in the selection for meta-analyses of binary data.","author":"Deeks"},{"key":"10.1002\/14651858.CD006391-BIB93|cit93","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior.","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD006391-BIB94|cit94","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB95|cit95","article-title":"Benzodiazepines alone or in combination with antipsychotic drugs for acute psychosis","author":"Gillies","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006391-BIB96|cit96","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD006391-BIB97|cit97","volume-title":"ECDEU Assessment Manual for Psychopharmacology (DOTES: Dosage Record and Treatment Emergent Symptom Scale)","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD006391-BIB98|cit98","volume-title":"ECDEU assessment manual for psychopharmacology","author":"Guy","year":"1976"},{"issue":"7414","key":"10.1002\/14651858.CD006391-BIB99|cit99","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses.","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006391-BIB100|cit100","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] The Cochrane Library 2005"},{"key":"10.1002\/14651858.CD006391-BIB101|cit101","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/1097-4679(196501)21:1<65::AID-JCLP2270210122>3.0.CO;2-I","article-title":"The nurses' observation scale for inpatient evaluation. A new scale for measuring improvement in chronic schizophrenia.","volume":"21","author":"Honigfeld","year":"1965","journal-title":"Journal of Clinical Psychology"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB102|cit102","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative symptome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB103|cit103","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001258","article-title":"Carbamazapine for schizophrenia and schizoaffective psychoses","author":"Leucht","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD006391-BIB104|cit104","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003834","article-title":"Lithium for schizophrenia","author":"Leucht","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006391-BIB105|cit105","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1037\/h0040653","article-title":"Evidence of ten psychotic symptoms","volume":"26","author":"Lorr","year":"1962","journal-title":"Journal of Consulting Psychology"},{"key":"10.1002\/14651858.CD006391-BIB106|cit106","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1176\/ajp.104.4.231","article-title":"A revision of the psychiatric rating scale","volume":"104","author":"Malamud","year":"1947","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB107|cit107","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia.","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD006391-BIB108|cit108","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD006391-BIB109|cit109","first-page":"431","article-title":"Clinical research for the treatment of schizophrenia","volume":"29","author":"Schooler","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD006391-BIB110|cit110","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD006391-BIB111|cit111","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD006391-BIB112|cit112","article-title":"Electroconvulsive therapy for schizophrenia","author":"Tharyan","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD006391-BIB113|cit113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta3050","article-title":"Methods for evaluating area-wide and organisation-based interventions in health and health care: a systematic review","volume":"3","author":"Ukoumunne","year":"1999","journal-title":"Health Technology Assessment"},{"issue":"4","key":"10.1002\/14651858.CD006391-BIB114|cit114","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000059","article-title":"Clozapine versus typical neuroleptic medication for schizophrenia","author":"Wahlbeck","year":"1999","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006391-BIB115|cit115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s002130100711","article-title":"Drop-out rates in randomised antipsychotic drug trials.","volume":"155","author":"Wahlbeck","year":"2001","journal-title":"Psychopharmacology"}],"updated-by":[{"DOI":"10.1002\/14651858.cd006391.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,11,14]],"date-time":"2012-11-14T00:00:00Z","timestamp":1352851200000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006391\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T14:25:03Z","timestamp":1683728703000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006391"}},"subtitle":[],"editor":[{"given":"Anja","family":"Volz","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2007,1,24]]},"references-count":115,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006391","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD006391.pub2","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2007,1,24]]}}}